These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25881087)

  • 1. "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.
    Idoko J; Folayan MO; Dadem NY; Kolawole GO; Anenih J; Alhassan E
    BMC Public Health; 2015 Apr; 15():349. PubMed ID: 25881087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.
    Idoko J; Folayan MO
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):127-34. PubMed ID: 26050385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.
    Emmanuel G; Folayan M; Undelikwe G; Ochonye B; Jayeoba T; Yusuf A; Aiwonodagbon B; Bilali C; Umoh P; Ojemeiri K; Kalaiwo A
    BMC Public Health; 2020 Jan; 20(1):69. PubMed ID: 31941469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What motivates serodiscordant couples to prevent HIV transmission within their relationships: findings from a PrEP implementation study in Kenya.
    Patel RC; Leddy AM; Odoyo J; Anand K; Stanford-Moore G; Wakhungu I; Bukusi EA; Baeten JM; Brown JM
    Cult Health Sex; 2018 Jun; 20(6):625-639. PubMed ID: 28903628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in awareness of and willingness to use pre-exposure prophylaxis and anticipated condom use among serodiscordant couples in Taiwan.
    Ko NY; Wu HJ; Strong C; Li CW; Ku WW; Hsu ST
    AIDS Care; 2018 Oct; 30(10):1306-1310. PubMed ID: 29845871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.
    Ngure K; Heffron R; Curran K; Vusha S; Ngutu M; Mugo N; Celum C; Baeten JM
    AIDS Patient Care STDS; 2016 Feb; 30(2):78-83. PubMed ID: 26836236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.
    Ying R; Sharma M; Heffron R; Celum CL; Baeten JM; Katabira E; Bulya N; Barnabas RV
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20013. PubMed ID: 26198348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
    Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
    AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples.
    Nakku-Joloba E; Pisarski EE; Wyatt MA; Muwonge TR; Asiimwe S; Celum CL; Baeten JM; Katabira ET; Ware NC
    J Int AIDS Soc; 2019 Jan; 22(1):e25225. PubMed ID: 30657642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "We are in this together:" dyadic-level influence and decision-making among HIV serodiscordant couples in Tanzania receiving access to PrEP.
    Fonner VA; Ntogwisangu J; Hamidu I; Joseph J; Fields J; Evans E; Kilewo J; Bailey C; Goldsamt L; Fisher CB; O'Reilly KR; Ruta T; Mbwambo J; Sweat MD
    BMC Public Health; 2021 Apr; 21(1):720. PubMed ID: 33853559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-negative male couples' attitudes about pre-exposure prophylaxis (PrEP) and using PrEP with a sexual agreement.
    Mitchell JW; Lee JY; Woodyatt C; Bauermeister J; Sullivan P; Stephenson R
    AIDS Care; 2016 Aug; 28(8):994-9. PubMed ID: 27055001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya.
    Carroll JJ; Ngure K; Heffron R; Curran K; Mugo NR; Baeten JM
    AIDS Care; 2016 Aug; 28(8):1000-6. PubMed ID: 26754017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'This is mine, this is for me': preexposure prophylaxis as a source of resilience among women in Eswatini.
    Bärnighausen KE; Matse S; Kennedy CE; Lejeune CL; Hughey AB; Hettema A; Bärnighausen TW; McMahon SA
    AIDS; 2019 Jun; 33 Suppl 1():S45-S52. PubMed ID: 31397722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples.
    Ngure K; Kimemia G; Dew K; Njuguna N; Mugo N; Celum C; Baeten JM; Heffron R
    J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21309. PubMed ID: 28361508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions among Dutch men who have sex with men and their willingness to use rectal microbicides and oral pre-exposure prophylaxis to reduce HIV risk--a preliminary study.
    Marra E; Hankins CA
    AIDS Care; 2015; 27(12):1493-500. PubMed ID: 26695133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.